Institut Curie

Research facility


Location: Paris, France (FR) FR

ISNI: 0000000406396384

ROR: https://ror.org/04t0gwh46

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Multicenter, International Assessment of the Eighth Edition of the American Joint Committee on Cancer Cancer Staging Manual for Conjunctival Melanoma (2019) Jain P, Finger PT, Damato B, Coupland SE, Heimann H, Kenawy N, Brouwer NJ, et al. Journal article PACIFIC-R: First real-world study of patients with unresectable, stage III NSCLC treated with durvalumab after chemoradiotherapy (2019) Girard N, Mornex F, Christoph DC, Fietkau R, Filippi AR, Field J, Garrido Lopez P, et al. Conference contribution A Consensus Molecular Classification of Muscle-invasive Bladder Cancer (2019) Kamoun A, Reyniès Ad, Allory Y, Sjödahl G, Gordon Robertson A, Seiler R, Hoadley KA, et al. Journal article CD8+ Cytotoxic Immune Infiltrate in Non-Muscle Invasive Bladder Cancer: A Standardized Methodology to Study Association with Clinico-Pathological Features and Prognosis (2019) Masson-Lecomte A, Maille P, Pineda S, Soyeux P, Sagrera A, Rava M, Lopez De Maturana E, et al. Journal article Kalman Inversion Stress Microscopy (2018) Nier V, Peyret G, d'Alessandro J, Ishihara S, Ladoux B, Marcq P Journal article Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility (2018) Machiela MJ, Gruenewald TGP, Surdez D, Reynaud S, Mirabeau O, Karlins E, Rubio RA, et al. Conference contribution Multiple new susceptibility loci identified in genome-wide association study of Ewing sarcoma (2018) Machiela MJ, Gruenewald TG, Surdez D, Reynaud S, Mirabeau O, Karlins E, Rubio RA, et al. Conference contribution Selumetinib in combination with dacarbazine in patients with metastatic uveal melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT) (2018) Carvajal RD, Piperno-Neumann S, Kapiteijn E, Chapman PB, Frank S, Joshua AM, Piulats JM, et al. Journal article Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial (2018) Ignatiadis M, Litiere S, Rothe F, Riethdorf S, Proudhon C, Fehma T, Aalders K, et al. Journal article Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility (2018) Machiela MJ, Grunewald TGP, Surdez D, Reynaud S, Mirabeau O, Karlins E, Rubio RA, et al. Journal article
1 ... 3 4 5 6 7